跳至主要内容
临床试验/NCT04867369
NCT04867369已完成4 期

Pecs II Block Versus Surgeon Infiltration for Open Subpectoral Biceps Tenodesis

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2021年7月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
160
试验地点
1
主要终点
Opioid Utilization for the First 24 Hours After Surgery

研究概览

简要总结

A phase IV, randomized, single-blind, single-center study measuring the effects of Pecs II block with 0.25% bupivacaine versus surgeon infiltration with 0.25% bupivacaine on postoperative pain control and opioid utilization in participants who undergo open subpectoral tenodesis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients between 18 and 75 years of age
  • Patients undergoing shoulder arthroscopy with open subpectoral biceps tenodesis

排除标准

  • Patients younger than 18 and older than 75;
  • Patients with a history of chronic pain that have used opioids for pain management for 3 months or longer;
  • Patients who are allergic to oxycodone;
  • Patients with diagnosed or self-reported cognitive dysfunction;
  • Patients with a history of neurologic disorder that can interfere with pain sensation;
  • Patients with a history of drug or recorded alcohol abuse;
  • Patients who are unable to understand or follow instructions;
  • Patients with severe liver disease, renal insufficiency, congestive heart failure, and/or significant heart disease;
  • Patients with an allergy or contraindication to any of the medications used in the study, or patients with a contraindication to any study procedures;
  • Patients with a BMI over 45;
  • Any patient that the investigators feel cannot comply with all study related procedures;
  • NYU Langone Health students, residents, faculty or staff members.

研究组 & 干预措施

Pecs II block

Experimental

80 patients scheduled for open biceps tenodesis

干预措施: Bupivacaine 20mL 0.5% (Drug)

Pecs II block

Experimental

80 patients scheduled for open biceps tenodesis

干预措施: Bupivacaine 20mL 0.25% (Drug)

Surgical infiltration

Active Comparator

80 patients scheduled for open biceps tenodesis

干预措施: Bupivacaine 20mL 0.5% (Drug)

Surgical infiltration

Active Comparator

80 patients scheduled for open biceps tenodesis

干预措施: Bupivacaine up to 15mL 0.25% (Drug)

结局指标

主要结局

Opioid Utilization for the First 24 Hours After Surgery

时间窗: Up to 24-Hours Post-Operation

Opioid utilization is calculated as morphine milligram equivalents (MME); measurement includes opioid utilization during surgery.

次要结局

  • Patient-reported Numerical Rating Scale (NRS) Score in Post Anesthesia Care Unit (PACU)(Typically 1-3 Hours Post-Operation)
  • Patient-reported Numerical Rating Scale (NRS) Score(Day 3 Post-Operation)
  • Number of Patients With Reactions to Surgical Subpectoral Incision - Movement(Intraoperative)
  • Number of Patients With Reactions to Surgical Subpectoral Incision - Tachycardia(Intraoperative)
  • Number of Patients With Reactions to Surgical Subpectoral Incision - Sensation in Bicep(Intraoperative)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验